ABBOTT'S TECH TAKES ON THE FLU

Flu has a significant economic impact on healthcare and society globally. Our tech helps people beat the illness.

Abbott's Tech Takes on the Flu

Feb 21 2020

The flu loves breaking the rules and this season is no exception.

Flu cases spiked earlier than normal and the virus that usually closes out the season (influenza B) showed up at the start instead. We’re left with a flu season that’s shaping up to be a bad one. A similarly severe season played out in the Southern Hemisphere, where flu tends to be most active from April to September.

The one thing people can count on during flu season is Abbott’s life-changing technologies to help care for them at all stages of the illness, from prevention (outside the United States only) to rapid diagnosis to recovery.

“Abbott is unique in that we have the vaccine outside the U.S. to make sure you don’t get sick, we have the ID NOWTM influenza test when you do have symptoms, and we have Pedialyte to help you rehydrate and feel better faster,” said Norman Moore, Ph.D., director of Scientific Affairs for Infectious Diseases in Abbott’s Rapid Diagnostics business.

Flu’s far-reaching cost

The flu spreads broadly and quickly, with up to 45 million people contracting the illness each year in the U.S. alone, according to the Centers for Disease Control and Prevention.

Not surprisingly, the global influenza market is vast, valued at about $6 billion and is expected to reach nearly $6.5 billion by 2022, according to BCC Research.

Get a closer look at the far-reaching cost of the flu and learn more about how we help people beat the illness from prevention to detection and recovery.

The Cost of Flu

 

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?